Abstract
BackgroundBreast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006. The ban ensued numerous complaints from patients such as pain, induration, deformation, infection, displacement, and milk deposition associated with PAAG injection. To date, no study has investigated the long-term effect of PAAG migration on autoimmune diseases.Case presentationWe report a rare case of a 49-year-old female patient with familial vitiligo who receiving PAAG injection for breast augmentation. The patient reported to have felt persistent movement of PAAG in her thoracoabdominal area for almost 20 years. Furthermore, the PAAG-induced chronic inflammation that aggravated vitiligo, which in turn promoted skin sclerosis. This damaged the breast contracture, increased chest tightness and induced mild breathing problems.ConclusionHere, we present a rare case in which a patient with a family history of vitiligo experienced long-term complications after receiving PAAG injection for breast augmentation. This case highlights the relationship between vitiligo, migration of PAAG and tissue hardening and skin contraction.Level of evidence: Level V
Highlights
Breast augmentation with polyacrylamide gel (PAAG) injection was approved in China in 1998 and later banned in 2006
Here, we present a rare case in which a patient with a family history of vitiligo experienced long-term complications after receiving Polyacrylamide gel (PAAG) injection for breast augmentation
This case highlights the relationship between vitiligo, migration of PAAG and tissue hardening and skin contraction
Summary
We present a rare case in which a patient with a family history of vitiligo experienced long-term complications after receiving PAAG injection for breast augmentation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have